APA (7th ed.) Citation

Peterson, E. D., Ashton, V., Chen, Y., Wu, B., & Spyropoulos, A. C. (2019). Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation. The American heart journal, 212, 113-119. https://doi.org/10.1016/j.ahj.2019.02.001

Chicago Style (17th ed.) Citation

Peterson, Eric D., Veronica Ashton, Yen-Wen Chen, Bingcao Wu, and Alex C. Spyropoulos. "Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Among Morbidly Obese Patients with Atrial Fibrillation." The American Heart Journal 212 (2019): 113-119. https://doi.org/10.1016/j.ahj.2019.02.001.

MLA (9th ed.) Citation

Peterson, Eric D., et al. "Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Among Morbidly Obese Patients with Atrial Fibrillation." The American Heart Journal, vol. 212, 2019, pp. 113-119, https://doi.org/10.1016/j.ahj.2019.02.001.